Why do we grow old? And is ageing really compulsory?
Jul 22nd 2010
The Youth Pill: Scientists at the Brink of an Anti-Ageing Revolution. By David Stipp. Current; 320 pages; $26.95
FOR as long as people have been growing old, they’ve been wishing they didn’t have to. The “Epic of Gilgamesh”, one of the most ancient works of literature, chronicles the eponymous hero’s quest for eternal life. Most religions offer an attenuated version of immortality in which some fuzzily defined soul endures even after the body has died. Medieval alchemists hunted in vain for the rejuvenating Philosopher’s Stone; industrial-age quacks got rich off their patent elixirs. Today, cosmetics companies dance around truth-in-advertising laws to imply that their creams and lotions can keep the years at bay.
Yet for all the gloomy fascination that surrounds ageing, precious little research has been done into its causes. The question of why we grow old and die still divides evolutionary biologists. Strictly speaking, ageing does not seem to be inevitable. After all, both cancer cells and some very simple forms of life appear highly resistant to the passage of time. And while we know plenty about the consequences of ageing, we know much less about the exact biological processes involved. The little interest shown was until recently limited to quacks and cranks, leavened with the occasional iconoclastic scientist (such as Peter Medawar, a brilliant British zoologist) with a reputation strong enough to survive developing an interest in a thoroughly disreputable field.
In the past couple of decades that has begun to change. Improvements in technology, particularly the ability to sequence DNA quickly, have made the serious study of ageing possible. All this is carefully chronicled in “The Youth Pill” by David Stipp, a former medical writer for the Wall Street Journal and an able guide to this young science. His book draws readers down the blind alleys and experimental dead ends that are an inevitable part of scientific research, as well as explaining the advances that have been made and the hunches that led to them.
Plenty of progress has already been made. Genes have been found that boost the lifespans of laboratory animals by 30% or more, and research into the mechanisms of ageing has fingered some tantalising leads: ageing seems to be associated with a low-level, chronic inflammation of many of the body’s tissues, for instance. Insulin, a hormone that regulates the metabolism of glucose, also crops up.
Most intriguing of all is something that scientists have known for decades: feeding near-starvation diets to laboratory animals such as mice and fruit flies can extend their lifespans by 40% or more, and improve health along the way. If those results translated directly to humans (and there is some preliminary evidence that fasting may confer benefits in people), then the human lifespan could reach 150 years. Many explanations have been offered and discarded to explain the power of dieting: that it reduces production of the harmful chemicals that are a side-effect of respiration, for instance, or that it lowers blood-sugar levels, which seems to have a variety of health benefits.
Instead, Mr Stipp propounds a relatively new theory that low-calorie diets activate genes designed to help animals endure hard times, which boost cellular repair mechanisms. There is evidence that almost all animals, including humans, may have a similar suite of genes. Proponents of this theory are searching for drugs, so-called “calorie-restriction mimetics”, that can produce these effects without requiring aspiring centenarians to endure 100 years of non-stop dieting. Several firms have been set up to capitalise on the findings, in the hope of developing and selling pills that grant longer, healthier lives.
The book’s tone is refreshing, although its occasional passages of lazy journalese can be jarring. Mr Stipp is clearly enthusiastic about the possibility of life-extension, and he mostly manages to avoid the breathless prose that mars so much reporting on the subject. Hype is an occupational hazard of anti-ageing research. There is a great temptation (rising with age) to inflate small advances into the idea that serious life extension, or even immortality, is just around the corner. It isn’t. But the discoveries of anti-ageing researchers suggest that some modest improvement in life expectancy, and a big reduction in the diseases of old age, are indeed pharmaceutically possible. Ageing, reckons Mr Stipp, is on the verge of becoming a respectable sub-discipline of medicine. That would be quite enough to constitute a revolution in its own right.
The final part of the book is philosophical, and considers whether extending lifespan is something worth aiming for. Some religious leaders and self-appointed sages have offered a variety of portentous reasons for embracing decrepitude instead of fighting it. Happily, Mr Stipp has little patience for such homilies, and demolishes them convincingly
Jul 22nd 2010
The Youth Pill: Scientists at the Brink of an Anti-Ageing Revolution. By David Stipp. Current; 320 pages; $26.95
FOR as long as people have been growing old, they’ve been wishing they didn’t have to. The “Epic of Gilgamesh”, one of the most ancient works of literature, chronicles the eponymous hero’s quest for eternal life. Most religions offer an attenuated version of immortality in which some fuzzily defined soul endures even after the body has died. Medieval alchemists hunted in vain for the rejuvenating Philosopher’s Stone; industrial-age quacks got rich off their patent elixirs. Today, cosmetics companies dance around truth-in-advertising laws to imply that their creams and lotions can keep the years at bay.
Yet for all the gloomy fascination that surrounds ageing, precious little research has been done into its causes. The question of why we grow old and die still divides evolutionary biologists. Strictly speaking, ageing does not seem to be inevitable. After all, both cancer cells and some very simple forms of life appear highly resistant to the passage of time. And while we know plenty about the consequences of ageing, we know much less about the exact biological processes involved. The little interest shown was until recently limited to quacks and cranks, leavened with the occasional iconoclastic scientist (such as Peter Medawar, a brilliant British zoologist) with a reputation strong enough to survive developing an interest in a thoroughly disreputable field.
In the past couple of decades that has begun to change. Improvements in technology, particularly the ability to sequence DNA quickly, have made the serious study of ageing possible. All this is carefully chronicled in “The Youth Pill” by David Stipp, a former medical writer for the Wall Street Journal and an able guide to this young science. His book draws readers down the blind alleys and experimental dead ends that are an inevitable part of scientific research, as well as explaining the advances that have been made and the hunches that led to them.
Plenty of progress has already been made. Genes have been found that boost the lifespans of laboratory animals by 30% or more, and research into the mechanisms of ageing has fingered some tantalising leads: ageing seems to be associated with a low-level, chronic inflammation of many of the body’s tissues, for instance. Insulin, a hormone that regulates the metabolism of glucose, also crops up.
Most intriguing of all is something that scientists have known for decades: feeding near-starvation diets to laboratory animals such as mice and fruit flies can extend their lifespans by 40% or more, and improve health along the way. If those results translated directly to humans (and there is some preliminary evidence that fasting may confer benefits in people), then the human lifespan could reach 150 years. Many explanations have been offered and discarded to explain the power of dieting: that it reduces production of the harmful chemicals that are a side-effect of respiration, for instance, or that it lowers blood-sugar levels, which seems to have a variety of health benefits.
Instead, Mr Stipp propounds a relatively new theory that low-calorie diets activate genes designed to help animals endure hard times, which boost cellular repair mechanisms. There is evidence that almost all animals, including humans, may have a similar suite of genes. Proponents of this theory are searching for drugs, so-called “calorie-restriction mimetics”, that can produce these effects without requiring aspiring centenarians to endure 100 years of non-stop dieting. Several firms have been set up to capitalise on the findings, in the hope of developing and selling pills that grant longer, healthier lives.
The book’s tone is refreshing, although its occasional passages of lazy journalese can be jarring. Mr Stipp is clearly enthusiastic about the possibility of life-extension, and he mostly manages to avoid the breathless prose that mars so much reporting on the subject. Hype is an occupational hazard of anti-ageing research. There is a great temptation (rising with age) to inflate small advances into the idea that serious life extension, or even immortality, is just around the corner. It isn’t. But the discoveries of anti-ageing researchers suggest that some modest improvement in life expectancy, and a big reduction in the diseases of old age, are indeed pharmaceutically possible. Ageing, reckons Mr Stipp, is on the verge of becoming a respectable sub-discipline of medicine. That would be quite enough to constitute a revolution in its own right.
The final part of the book is philosophical, and considers whether extending lifespan is something worth aiming for. Some religious leaders and self-appointed sages have offered a variety of portentous reasons for embracing decrepitude instead of fighting it. Happily, Mr Stipp has little patience for such homilies, and demolishes them convincingly
ليست هناك تعليقات:
إرسال تعليق